Clearline Capital’s Cigna CI Stock Holding History

Clearline Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,015	Closed	-$506K	–	54
2018 Q1	$506K	Buy	+3,015	New	+$586K	0.47%	36
2017 Q2	–	Sell	-2,250	Closed	-$330K	–	44
2017 Q1	$330K	Buy	+2,250	New	+$332K	0.16%	55

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Clearline Capital's CI Position: Q2 2018 in Review

Clearline Capital sold out of Cigna (CI) in Q2 2018, closing a stake of 3,015 shares — an estimated $506K sold.

Clearline Capital first reported a position in CI in Q1 2017 and held it in 2 quarters. The position peaked at $506K in Q1 2018. 858 funds tracked by Wall St. Rank hold CI as of Q2 2018.

Clearline Capital reported no remaining Cigna position as of Q2 2018 after selling out during the quarter.
Clearline Capital sold 3,015 Cigna shares in Q2 2018, an estimated $506K.
Clearline Capital first reported a position in Cigna in Q1 2017 and held it in 2 quarters.
Clearline Capital's Cigna position peaked at $506K in Q1 2018.
858 funds tracked by Wall St. Rank held Cigna as of Q2 2018.

Based on Clearline Capital's 13F filing for Q2 2018, filed 14 Aug 2018.